CONTENTS:
- Engaging with people who use image and performance enhancing drugs: One size does not fit all. McVeigh J., p. 1-2.
- Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology. Daniulaityte R., Carlson R.R., Juhascik M.P., Strayer K.E., Sizemore I.E., p. 3-9.
- 'Never drop without your significant other, cause that way lies ruin': The boundary work of couples who use MDMA together. Anderson K., Reavey P., Boden Z., p. 10-18.
- Social inclusion from on high: A poststructural comparative content analysis of drug policy texts from Canada and Scotland. Allman D., p. 19-28.
- Canada, cannabis and the relationship between UN child rights and drug control treaties. Barrett D., p. 29-35.
- Overview of "home" cultivation policies and the case for community-based cannabis supply. Belackova V., Roubalova M., van de Ven K., p. 36-46.
- The opioid crisis and the infrastructure of social capital. Sered S.S., p. 47-55.
- Care, agency and criminality: Making sense of authorised extended distribution in the accounts of key stakeholders. Bryant J., Brener L., Pepolim L., Harrod M.E., p. 56-61.
- Pharmacists' attitudes and practices about selling syringes to people who inject drugs in Tajikistan: Results of a syringe purchase audit and a survey. Ibragimov U., Haardörfer R., Cooper H.L.F., Dunkle K.L., Zule W.A., Wong F.Y., p. 62-72.
- Stigma towards people who use drugs: A case vignette study in methadone maintenance treatment clinics in China. Luo S., Lin C., Feng N., Wu Z., Li L., p. 73-77.
- Attitudes toward legalization of marijuana in the United States, 1986-2016: Changes in determinants of public opinion. Denham B.E., p. 78-90.
- Methadone in primary care in France: Using evidence for action against hepatitis C [Commentary]. Roux P., Morel A., Wolfe D., Carrieri P., p. 91-92.
- Progress of smoke-free policy adoption at district level in Indonesia: A policy diffusion study. Septiono W., Kuipers M.A.G., Ng N., Kunst A.E., p. 93-102.
- The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys. Degenhardt L., Bharat C., Glantz M.D., Sampson N.A., Scott K., Lim C.C.W., et al., p. 103-112.
- Pharmacist dispensed naloxone: Knowledge, availability, participation and cost in selected California counties. Darracq M.A., Lee J., Wilson T., Lasoff D., Armenian P., p. 113-117.
- "They're making it so hard for people to get help:" Motivations for non-prescribed buprenorphine use in a time of treatment expansion. McLean K., Kavanaugh P.R., p. 118-124.
- "We don't got that kind of time, man. We're trying to get high!": Exploring potential use of drug checking technologies among structurally vulnerable people who use drugs. Bardwell G., Boyd J., Tupper K.W., Kerr T., p. 125-132.
- Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers. Bucerius S.M., Haggerty K.D., p. 133-138.